LiNa Biotech has developed a high-performance cancer diagnosis system based on our patented personalized Microfluidic-Elasto-Filtration technology for isolating circulating tumor cells (CTC).
Current Status
We are currently seeking our Series A funding, with several projects ongoing focused on research and clinical trials, in collaboration with hospitals and laboratories.
Problem or Opportunity
Cancer diagnosis and information on cancer status are very limited, expensive, and time-consuming.
Solution (product or service)
We offer a new system based on our own patented technology for high-accuracy CTC enumeration which can be used for cancer diagnosis and cancer monitoring.
Business model
We will sell our system to hospitals, laboratories, and research institutions; and sell our testing services to our clients.
